| T1015 | Clinic visit/encounter, all-inclusive | 456 | 1,550 | 38,050 | $190 | $14.1M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 669 | 750 | 950 | $50 | $890K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 85 | 270 | 950 | $30 | $378.2K |
| Z7500 | N/A | 15 | 180 | 620 | $20 | $237.4K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which… | 222 | 1,030 | 1,050 | $70 | $219.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,689 | 13,300 | 640 | $40 | $169.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 3,438 | 4,230 | 210 | $110 | $135K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 797 | 14,520 | 760 | $10 | $122.8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 487 | 520 | 470 | $10 | $116K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 874 | 1,210 | 420 | $30 | $95.7K |